Monday - November 25, 2024
Senate Health, Education, Labor & Pensions Committee Issues Testimony From Novo Nordisk President Jorgensen
October 17, 2024
WASHINGTON, Oct. 17 -- The Senate Health, Education, Labor and Pensions Committee released the following testimony by Lars Fruergaard Jorgensen, president and CEO of Novo Nordisk from a Sept. 24, 2024, hearing entitled "Why Is Novo Nordisk Charging Americans With Diabetes and Obesity Outrageously High Prices for Ozempic and Wegovy?":

* * *

Chairman Sanders, Ranking Member Cassidy, and Members of the Committee, thank you for the opportunity to participate in to . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products